Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors (PRO-BAC)

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Status: Completed

Conditions: Bacteremia

Study type: Observational

Funder types: Other

Identifiers

NCT03148769

FIS-AMO-2016-01

Details and patient eligibility

About

Bacteremia

The Hypothesis of the study are the followings:

• To demonstrate relevant epidemiologic and clinical changes with potentially impact in the management and prognosis of the patients with bacteremia.
• Since the diagnosis and management is heterogeneous between centers, we could identify a scenario to improve.
• To identify quality indicators in the management of bacteremia.
• To demonstrate that some interventions made by Bacteremia Team pose relevant impact in the prognosis of bacteremia.

Enrollment: 5,320 patients

Sex: All

Ages: 13+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Every episode of bacteremia in patients older than 13 years old, confirmed microbiologically and clinically significant (presence of clinical sepsis data at diagnosis) should be prospectively included on the basis of standard criteria.
• Episodes of transient bacteremia may be included.
• Drugs will be prescribed in the usual way, according to the conditions established in the authorization. The assignment of a patient to a particular therapeutic strategy will not be decided in advance by the study protocol, but will be determined by the usual clinical practice, and the decision to prescribe a particular drug will be clearly dissociated from the decision to include to the patient in the study.

Exclusion criteria

• Bacteremias without clinical relevance